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31 Abstract
2 The gut microbiota is involved in the regulation of the intestinal permeability (IP), whose 
3 disruption is a frequent condition in older people and is associated to the development of 
4 several diseases. The diet can affect the gut microbiota and IP, although the molecular 
5 mechanisms involved are unclear. Metabolomics is one of the suitable approaches to 
6 study the effects of diet on gut microbiota and IP, although up to now the research has 
7 focused only on few dietary components. The aim here was to review the most recent 
8 literature concerning the application of metabolomics to the study of the diet-induced 
9 alterations of gut microbiota and the effects on IP, with a particular focus on the molecular 
10 pathways involved. An additional aim was to give a perspective on the future research 
11 involving dietary polyphenols, because despite their potential use in the management of 
12 increased IP, few studies have been reported to date.
13
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426 Introduction 
27 The gastrointestinal tract (GI) is responsible for a wide range of functions, including 
28 digestion and absorption of nutrients, water and ions, regulation of host immunity, 
29 protection against the ingress of pathogenic microorganism, and the the metabolism and 
30 detoxification of xenobiotics. The GI also hosts the largest microbial population of the 
31 human body, which works in symbiosis with the host to accomplish these various 
32 intestinal functions. Gut bacteria are particularly important for host health, being involved 
33 in the synthesis of vitamins, secondary bile acids and neurotransmitters, and playing a 
34 direct role in the metabolism and degradation of dietary components and drugs, that can 
35 affect their bioavailability and absorption 1. It has been estimated that over than 1,000 
36 different bacterial species populate the intestinal environment, with a genome comprising 
37 100-fold more genes than those found in human genome 2. The physiological variations 
38 in the small intestine and colon, such as the presence of distinct chemical environments, 
39 nutrients and host immune activity allow distinct groups of bacterial species to populate 
40 the different regions of the lower gastrointestinal tract 3,4, and this variability becomes 
41 even more complex considering the inter-individual variations and the influence of host 
42 genetics 5-7. Nevertheless, most human gut microbiota share a core set of resident bacteria 
43 and related microbial genes 8,9. Firmicutes, Bacteroidetes and, secondly, Actinobacteria 
44 are the three most abundant phyla, among the over 50 that have been identified by 
45 metagenomic approaches 10,11. A synergistic equilibrium among the different species and 
46 the maintenance of a microbial diversity are of crucial importance for health, since the 
47 microbiota plays a central role on the proper functioning of the intestinal barrier and 
48 maintaining appropriate intestinal permeability (IP), which is directly involved in the 
49 development of numerous disorders.  In this vein, a low diversity and a scarce abundance 
50 of species as Bifidobacterium spp. and Faecalibacterium prausnitzii have been associated 
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551 with gut disease states, e.g. Crohn’s disease 12, type 1, type 2 and gestational diabetes 13-
52 15, celiac disease 16 and obesity 17.  
53 Diet, as a source of macro- and micro-nutrients and other bioactive components, is one 
54 of the factors that most can affect the microbiota. Among the dietary constituents, 
55 polyphenols have been in the spotlight in recent years, due to their particular 
56 physicochemical properties and their potential to directly affect microbiota activity and 
57 host health. Polyphenols are secondary metabolites of plants, fruits and vegetables, and 
58 major components of commonly consumed foods and beverages such as chocolate, tea 
59 and coffee 18-20 which, due to their characteristic (poly)hydroxylated phenyl moieties and 
60 the presence of ionizable functional groups on their scaffolds, have a low bioavailability 
61 and are scarcely absorbed by the intestine 21,22. Consequently, they are prone to catabolism 
62 by the gut microbiota, which leads to the production of smaller molecular weight (MW) 
63 compounds that can be absorbed across the intestinal wall, enter the bloodstream and 
64 eventually, undergo further transformation and conjugation in the liver 23,24. It has been 
65 estimated that total polyphenol absorption in the small intestine is around 5%–10%, while 
66 the remaining 90%–95% transits to the large intestinal lumen and accumulates in the 
67 millimolar range 25. Hence, microbial polyphenol derivatives could be responsible for the 
68 biological effects attributed to their parent compounds, or at least contribute to the overall 
69 activity. Catechins from green tea, for example, have been reported to exert antioxidant, 
70 anti-inflammatory and anti-tumorigenic activities 26-28. However, the most representative 
71 green tea catechin, (−)-epigallocatechin gallate, is scarcely absorbed from the intestine 
72 and is extensively metabolized by gut microbiota 29 to form smaller MW derivatives that 
73 not only contribute to the observed bioactivities of green tea, but can also exert higher 
74 activity than the parent compound 30. Polyphenols and their microbial metabolites could 
75 also exert antimicrobial and bacteriostatic activities, hence regulating the overgrowth of 
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676 harmful bacteria on the intestinal and urinary tract epithelia 20,31. As an example, 
77 cranberry (Vaccinium macrocarpon Ait.) fruits, rich sources of type-A procyanidins 
78 (PAC-A), are known to exert anti-adhesive activity against the uropathogenic bacteria 
79 responsible for most of the lower urinary tract infections, although the mechanisms of 
80 action are still unknown and the outcomes of in vitro assays and in vivo clinical trials 
81 aimed at reducing urinary tract infections are frequently inconsistent 32. Recent studies 
82 conducted in both rats and human volunteers show that, after supplementation with dry 
83 cranberry extracts, urine samples exert effective anti-adhesive activity against 
84 uropathogenic E. coli, despite their negligible contents of intact PAC-A 33,34. However, 
85 the same urine samples were characterized by high amounts of hydroxyphenyl-valeric 
86 acid and hydroxyphenyl-valerolactone derivatives, previously reported as end-products 
87 of microbial degradation of flavan-3-ols 35, indicating the important contribution of the 
88 microbial metabolites of procyanidins to the observed bioactivity 33,34. Finally, the effects 
89 of polyphenols on microbiota, inflammation and oxidative stress and their capacity to 
90 regulate the synthesis and expression of specific proteins on the intestinal epithelium 
91 seem to be part of the mechanisms by which these compounds can regulate the 
92 permeability of the intestinal barrier 36, whose alterations are related to the development 
93 of several diseases, especially in older subjects. 
94 Many efforts have been made to characterize the microbial community colonizing the 
95 human intestine, for which the widespread use of metataxonomics based on 16S rRNA 
96 gene profiling and metagenomics (microbiomics) has been particularly important. 
97 However, although representing powerful tools for bacterial identification and 
98 classification, microbiomics does not allow to obtain information about fluctuations in 
99 metabolic activities 1. To this purpose, metabolomics is the most suitable approach, and 
100 numerous reports based on metabolomic analysis have been reported over the last decade 
Page 6 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
7101 37. Focusing on the application of metabolomics in the study of diet-microbiota 
102 interactions and searching for the keywords “metabolomics AND diet AND microbiota” 
103 in PubMed, we found that the number of publications almost doubled from 2014 to 2018, 
104 as an index of the popularity that metabolomics gained during the recent years (Figure 1). 
105 Metabolomic approaches have been widely used to study the transformation of nutrients 
106 and xenobiotics by intestinal microbiota 38-43, thus allowing the characterization of 
107 hundreds of metabolites derived from macro- and micronutrients and polyphenols coming 
108 from fruits and vegetables. In 2009, Jacobs published a first review article regarding the 
109 role of colonic microbiota in the degradation of non-digestible food ingredients and their 
110 impact on gut health and immunity 44. For the first time, the importance of metabolomics 
111 in the study of the links between the bioconversion of non-digestible food ingredients, 
112 their bioavailability and their downstream effects on microbiota composition and host 
113 metabolism was recognized 44. More recently, the use of integrated multi-omics 
114 approaches has facilitated the study of the molecular interactions between diet and 
115 microbiota, and has led to the identification of several metabolites that are produced as a 
116 result of microbial metabolism of various dietary constituents. Nevertheless, considering 
117 the challenges to study the mutual relationship between gut microbiota and the host, its 
118 tight connection with diet, environment and lifestyle, and the still incomplete 
119 characterization of the huge microbial metabolome, the path to assess precise and 
120 validated metabolites to link the microbial activity to specific effects on health is just 
121 starting. In a way to find a clinical relevance of metabolomics data and offer to clinicians 
122 a robust tool to predict, prevent and treat several diseases, further progress is necessary.  
123 The aim of this work was to review the most recent literature regarding the application of 
124 metabolomics in the study of the interactions between food components and gut 
125 microbiota and the effects on IP, with a particular focus on the elucidation of the 
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8126 molecular pathways involved. Since to date the research has mainly focused on the 
127 degradation of non-digestible fibers and tryptophan and on the bioactivity of their 
128 metabolites, a major part of the work will be dedicated to these important dietary 
129 components. Additionally, a perspective on the future research involving the role of 
130 dietary polyphenols in modulating the activity and composition of gut microbiota and the 
131 effects on IP will be discussed, given that, despite their potential implication in the 
132 prevention and treatment of several diseases, few clinical studies have been performed up 
133 to now. 
134
135 The role of microbiota and microbiota-derived dietary metabolites in regulating 
136 intestinal permeability: the application of metabolomics for the discovery of new 
137 biomarkers
138 The intestinal wall represents a barrier that selectively transports nutrients, ions and water 
139 from the lumen to the bloodstream, via passive and active mechanisms. A layer of 
140 epithelial cells constitutes the main physical barrier between the intestinal lumen and the 
141 mucosal tissues 45. Tight junctions (TJ), composed of transmembrane proteins and 
142 junctional adhesion molecules that regulate the flow of water, ions and small molecules, 
143 seal the paracellular spaces 46. Several distinct proteins contribute to form the TJ, 
144 including mainly occludins and claudins, depending on the tissue and location that 
145 interlink within the paracellular space 47. Although highly cross-linked, the structure of 
146 TJ is dynamic, so that it can be ‘opened’ and ‘closed’ following specific stimuli 48. 
147 Physiological stimuli could shrink the TJ to prevent the diffusion of toxins, viruses or 
148 bacterial fragments to the mucosal layer, while they can open the paracellular space to 
149 allow the diffusion of nutrients 49. For instance, the activation of the sodium dependent 
150 glucose transporter led to the opening of TJ and allowed the diffusion of small molecules 
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9151 and peptides with MW < 40,000 Da 50. On the other hand, the physiological structure and 
152 dynamism of TJ could be altered due to pathological states 51, leading to a condition of 
153 increased IP, also known as “leaky gut”. Celiac disease, inflammatory bowel disease and 
154 type I diabetes are three of the principal pathological causes of leaky gut 52, which leads 
155 to the permeation of potentially harmful molecules, organisms or microbial fragments 
156 from the intestinal lumen to the mucosal layer, inducing a cascade of events that result in 
157 immune activation and local or systemic inflammation. Older people are frequently 
158 affected by decreased intestinal barrier function and consequently leaky gut 53. Among 
159 the causes, the aging-related decline of immune function (namely immune-senescence), 
160 the remodeling of intestinal epithelium and the alterations of gut microbiota composition 
161 are thought to be the most important ones 53-55. As observed in disease-associated 
162 increased IP, the dysfunction of the intestinal barrier in older subjects facilitates the 
163 diffusion of toxic substances or peptides and microbial fragments to the mucosal layer 
164 and to the bloodstream and the triggering of a systemic inflammatory response 56. 
165 As previously stated, diet plays an important role in the maintenance of the gut barrier 
166 integrity and is hence determinant for IP. The short-chain fatty acids (SCFAs), produced 
167 by the degradation of dietary fibers by several bacteria in the gut (including Clostridium, 
168 Eubacterium, and Butyrivibrio), have been the most studied microbial catabolites 
169 involved in the regulation of IP to date. Among them, butyrate has been identified as a 
170 marker of the positive effects of non-digestible dietary fiber consumption on microbiota 
171 composition and intestinal permeability. It exerts several activities on the intestinal wall, 
172 such as controlling inflammation by altering the expression of pro-inflammatory 
173 cytokines 57, preserving the intestinal barrier function by inducing the expression of TJ 
174 proteins claudin-1 and claudin-2 58, and modulating composition of gut microbiota by 
175 inhibiting the growth of pathogenic bacteria 59 (Figure 2). Food is the only source of non-
Page 9 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
10
176 digestible carbohydrates, and alterations in diet lead to variations in the production of 
177 intestinal butyrate. In aged mice, the increased butyrate production after the consumption 
178 of high doses of soluble fiber was associated with an induced expression of the TJ proteins 
179 Tjp2 and Ffar2 and to a counterbalance of the age-related microbiota dysbiosis, with a 
180 significant amelioration of the increased IP condition typical of older individuals 60. 
181 Similar effects of a high fiber diet were also observed in mice affected by autoimmune 
182 hepatitis, characterized by an imbalance of Treg/Th17 cells and increased IP 61. 
183 Metabolomics analysis of feces showed increased levels of butyrate after dietary 
184 intervention, and the expression of TJ proteins ZO-1, occludin and claudin-1 was induced 
185 in the ileum, with consequent increased intestinal barrier function and decreased 
186 translocation of bacterial components through the intestinal wall 61 (Table 1). The same 
187 effects were also observed in mice treated with sodium butyrate, indicating a direct 
188 involvement of this bacterial metabolite in the regulation of IP 61. Similar results were 
189 recently reported by Fachi and coll., who showed that an inulin-enriched diet protects 
190 mice from Clostridium difficile-induced colitis through the production of SCFAs 62. 
191 Metabolomics analysis of feces showed the increased production of butyrate, propionate 
192 and acetate after dietary intervention (Table 1). Butyrate reduced the levels of pro-
193 inflammatory cytokines and increased the anti-inflammatory cytokine IL-10 in the colon 
194 at the peak of infection, leading to an overall attenuation of the intestinal inflammation 
195 62. Butyrate induced the expression of genes associated with claudin-1 and occludin, 
196 leading to a reduction of the IP and consequently to a reduction of the microbial 
197 translocation in the liver and spleen 62. 
198 Microbial tryptophan metabolites also play an important role in regulating barrier 
199 functions and gut microbiota activity. A metabolomic approach allowed to obtain 
200 preliminary elucidations about the role of tryptophan and its microbial and endogenous 
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201 derivatives in the regulation of immune tolerance toward intestinal microbiota 63. Starting 
202 from these findings, further research has elucidated the role of other microbial-derived 
203 tryptophan metabolites in the regulation of gut permeability, by direct effects on epithelial 
204 cells. Venkatesh et al. showed that indole-3-propionic acid (IPA), produced by the 
205 firmicute Clostridium sporogenes, regulates mucosal integrity and intestinal barrier 
206 function by activating the pregnane X receptor (PXR) and upregulating junctional 
207 protein-coding mRNAs 64. More recently, Dodd et al. used an integrated targeted-
208 untargeted approach to identify 12 microbial metabolites derived from the reductive 
209 activity of C. sporogenes on aromatic amino acids (phenylalanine, tyrosyne and 
210 tryptophan), of which nine (lactate, acrylate and propionate derivatives) were reported to 
211 accumulate in host plasma 65. The authors particularly focused on IPA and its effects on 
212 gut barrier and the mucosal immune system, and their results supported the findings of 
213 Venkatesh and coll. about the PXR-mediated effect on gut permeability 64,65 (Table 1). A 
214 treatment with 20 mg kg−1 IPA for four consecutive days was shown to significantly 
215 decrease the IP in HFD-fed obese T2D mice 66, which, prior to treatment, were 
216 characterized by higher IP and lower circulating IPA levels compared to lean animals. 
217 Plasma IPA amounts were also reported to increase in obese subjects 3 months after 
218 Roux-en-Y gastric bypass (RYGB) surgery 66, indicating, once again, the direct 
219 involvement of gut microbiota in the maintenance of the intestinal barrier functions. 
220 Furthermore, results from in vitro assays reported by the same authors showed that IPA 
221 could reduce the permeability of T84 cell monolayer compromised by pro-inflammatory 
222 cytokines 66. Other metabolites derived from the same degradation pathway of 
223 tryptophan, i.e. indole (produced by Escherichia coli, Clostridium bifermentans, Proteus 
224 vulgaris, Paracolobactrum coliforme, Achromobacter liquefaciens, and Bacteroides 
225 spp.) 67, indole-3-acetic acid (produced by C. sporogenes) and tryptamine (produced by 
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226 C. sporogenes and Ruminococcus gnavus) 68, were also reported to exert anti-
227 inflammatory activity both in the intestinal lumen and in the liver 68,69, and to up-regulate 
228 the expression of several proteins involved in the trans-epithelial cells linkage on the 
229 intestinal wall, such as tight junction proteins TJP1, TJP3, and TJP4, and gap junction 
230 proteins GJE1, GJB3, GJB4, and GJA8, among others 67. A schematic resume of these 
231 results is reported in Figure 2.
232 In recent years, polyphenols have been widely considered for their beneficial effects on 
233 health and polyphenol-rich diets have been evaluated for the prevention of several chronic 
234 diseases, ranging from metabolic disorders to inflammation and cancer. Some studies 
235 have also evaluated the consumption of polyphenol-rich food for the prevention of 
236 diseases associated to aging, such as cognitive impairment 70 and depression 71, although 
237 up to now the reported effects have been inconsistent. However, numerous in vitro and 
238 animal studies show that the consumption of polyphenol-rich food could positively affect 
239 IP, reinforcing the barrier properties of the intestinal epithelium by direct influence on the 
240 synthesis and expression of tight junction proteins 72,73 or by interaction with gut 
241 microbiota. As previously described, this latter is directly involved in the metabolic 
242 transformation of plant polyphenols and in the production of smaller MW derivatives 74, 
243 which in turn contribute to the maintenance of barrier function and drives changes in gut 
244 microbiome constituents 75,76, with important effects for host health. However, although 
245 several molecular targets of dietary polyphenols and their metabolites on the intestinal 
246 epithelium have been elucidated 77, it is unclear how the interaction of the same 
247 compounds with gut microbiota leads to beneficial effects on the intestinal barrier. In 
248 recent studies, through integrated metagenomics-metabolomics analyses of feces and 
249 plasma, some authors correlated the variations of the amounts of specific gut-derived 
250 metabolites to the effects of polyphenol ingestion on IP (Table 1). It was observed that a 
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251 high-fat diet supplemented with 4% w/w powdered green tea leaves rich in flavanols leads 
252 to an increased intestinal population of Akkermansia spp. after 22 weeks 78, a bacterium 
253 that has been implied in the maintenance of a functional intestinal barrier through the 
254 preservation of mucus layer thickness 79. Li et al.  reported that the consumption of a 
255 medium-dose (20 mg/kg per day) of bilberry anthocyanin extract (BAE) promoted the 
256 generation of SCFAs (acetic acid, propionic acid and butyric acid) in aging rats, through 
257 the regulation of the intestinal microbiota 80. Specifically, several starch-utilizing and 
258 butyrate-producing bacteria (among whom Lactobacillus and Bacteroides) were induced 
259 by BAE, while harmful species such as Verrucomicrobia and Euryarchaeota where 
260 inhibited. These variations, associated with decreased levels of TNF-α and IL-6 in the 
261 colon induced by BAE consumption, contributed to the restoring of the intestinal barrier 
262 function typically altered in older individual 80. In a more recent work by Nieman and 
263 coll., the authors observed the effects of the association of acute moderate physical 
264 activity (sustained walking for 45 min and moderate-intensity running for 2.5 h) and a 
265 two-week flavonoid supplementation on the IP in healthy volunteers 81. The results, 
266 obtained using a targeted metabolomics approach, showed that acute moderate exercise 
267 leads to higher circulating amounts of 15 metabolites derived from flavonoids metabolism 
268 by gut microbiota (mainly hippuric acid, methoxybenzoic acid and benzaldehyde 
269 derivatives; Table 1). The increased levels of these compounds were correlated to the 
270 significant decrease of IP observed in both “walking” and “running” groups of volunteers, 
271 although information about the mechanism(s) of action involved are lacking 81. 
272 Overall, the data published up to now indicate that the effects of polyphenols on IP are 
273 related to both direct activity on the expression of TJ proteins and to changes induced to 
274 the intestinal microbiota, with an increase in the prevalence of species that can preserve 
275 barrier functions through the production of active metabolites or by direct action on the 
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276 mucous layer (Figure 2). On the other hand, the data supporting these observations are 
277 still scarce, and up to now only few compounds (e.g. butyrate and some gut-derived 
278 polyphenol metabolites) correlating the polyphenol-induced modifications of gut 
279 microbiota to the effects on the intestinal integrity and permeability have been discovered. 
280 Nevertheless, as demonstrated by the works of Li 80 and Nieman 81, the integration of 
281 metagenomics and metabolomics approaches for the study of the bacterial and metabolic 
282 composition of feces and biological fluids represents one of the most suitable approaches 
283 for the identification of the pathways leading to the effects of polyphenols on gut 
284 microbiota and IP, as well as for the assessment of the key metabolites involved. 
285
286 Conclusion and future perspective
287 Although the study of the effects of dietary interventions on gut microbiota and IP and 
288 investigations of the mechanisms of action have begun only recently, it appears clear that 
289 appropriate dietary habits and the regular consumption of vegetables and fruits rich in 
290 fibers and polyphenols play an important role in the maintenance of proper intestinal 
291 functions. The precursors of SCFAs and of several indole or phenolic derivatives 
292 produced by bacterial catabolism in the intestinal lumen, for example, are abundant 
293 constituents of both plant-derived foods, as cereals, nuts, fruits and vegetables rich in non-
294 digestible fibers 82, and animal-based foods such as dairy products, eggs and meat, which 
295 are rich sources of tryptophan 83. Thanks to the employment of integrated multi-omics 
296 approaches, the involvement of several partners (food components, microbiota and 
297 microbial-derived compounds) in the maintenance of the intestinal barrier function and 
298 the molecular pathways behind this activity are being gradually elucidated, although 
299 further efforts are required to link specific food components and their metabolites to 
300 specific mechanisms of action. Nevertheless, the increasing amounts of data regarding 
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301 specific metabolites (e.g. physicochemical properties, spectroscopic properties, location 
302 in biofluids, involvement in metabolic pathways) stored in freely available databases and 
303 the affordability of even more sensitive and robust instrumentations will allow, in the near 
304 future, to obtain further biological information to better understand the molecular 
305 mechanisms behind the effects of diet on gut microbiota and IP. Once that both 
306 metabolites and molecular pathways will be assessed and validated for clinical relevance, 
307 they will represent novel instruments available to clinicians for the assessment of the 
308 “intestinal health” and for the development of dietary plans aimed at managing and 
309 preventing diseases directly linked to increased IP, as chronic inflammation and 
310 immunological disorders, which are determinant for the gradual decline of health in older 
311 subjects.
312
313 Funding
314 This work was supported by the Spanish Ministry of the Economy and Competitiveness 
315 (MINECO) together with the Joint Programming Initiative “A Healthy Diet for a Healthy 
316 Life” (JPI HDHL, http://www.healthydietforhealthylife.eu) under the Intestinal-
317 Microbiomics call (2015), Grant MAPLE-PCIN-2015-238 and the respective Research 
318 Councils: Mipaaf (Italy; D.M. 8245/7303/2016), the Biotechnology and Biological 
319 Sciences Research Council (UK; Grant BB/R012512/1). MAPLE “Gut and blood 
320 microbiomics for studying the effect of a polyphenol-rich dietary pattern on intestinal 
321 permeability in the elderly” was funded Funds from CIBERFES [co-funded by the 
322 European Regional Development Fund (FEDER) program from the European Union 
323 (EU)]. The authors also gratefully acknowledge the award from the Generalitat de 
324 Catalunya’s Agency for Management of University and Research Grants (AGAUR, Grant 
325 2017SGR1566). RGD thanks the “Juan de la Cierva” program from MINECO (FJCI-
Page 15 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
16
326 2015-26590). CA-L gratefully acknowledges the financial support by ICREA under the 
327 ICREA Academia programme.
328
329 References
330
331 1. Rowland, I.; Gibson, G.; Heinken, A.; Scott, K.; Swann, J.; Thiele, I.; Tuohy, K. 
332 Gut microbiota functions: metabolism of nutrients and other food components. 
333 Eur. J. Nutr. 2018, 57, 1-24.
334 2. Guinane, C.M.; Cotter, P.D. Role of the gut microbiota in health and chronic 
335 gastrointestinal disease: Understanding a hidden metabolic organ. Ther. Adv. 
336 Gastroenterol. 2013, 6, 295-308.
337 3. Donaldson, G.P.; Lee, S.M.; Mazmanian, S.K. Gut biogeography of the bacterial 
338 microbiota. Nat. Rev. Microbiol. 2015, 14, 20-32.
339 4. Hillman, E.T.; Lu, H.; Yao, T.; Nakatsu, C.H. Microbial ecology along the 
340 gastrointestinal tract. Microbes Environ. 2017, 32, 300-313.
341 5. Grice, E.A.; Segre, J.A. The human microbiome: Our second genome. Annu. Rev. 
342 Genomics Hum. Genet. 2012, 13, 151-170.
343 6. Ussar, S.; Fujisaka, S.; Kahn, C.R. Interactions between host genetics and gut 
344 microbiome in diabetes and metabolic syndrome. Mol. Metab. 2016, 5, 795-803.
345 7. Hornung, B.; Martins dos Santos, V.A.P.; Smidt, H.; Schaap, P.J. Studying 
346 microbial functionality within the gut ecosystem by systems biology. Genes Nutr. 
347 2018, 13, 5. 
348 8. Turnbaugh, P.J.; Gordon, J.I. The core gut microbiome, energy balance and 
349 obesity. J. Physiol. 2009, 587, 4153-4158.
Page 16 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
17
350 9. Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem. J. 2017, 
351 474, 1823-1836.
352 10. Turnbaugh, P.J.; Hamady, M.; Yatsunenko, T.; Cantarel, B.L.; Duncan, A.; Ley, 
353 R.E.; Sogin, M.L.; Jones, W.J.; Roe, B.A.; Affourtit, J.P.; Egholm, M.; Henrissat, 
354 B.; Heath, A.C.; Knight, R.; Gordon, J.I. A core gut microbiome in obese and lean 
355 twins. Nature 2009, 457, 480-484.
356 11. Claesson, M.J.; Cusack, S.; O'Sullivan, O.; Greene-Diniz, R.; De Weerd, H.; 
357 Flannery, E.; Marchesi, J.R.; Falush, D.; Dinan, T.; Fitzgerald, G.; Stanton, C.; 
358 Van Sinderen, D.; O'Connor, M.; Harnedy, N.; O'Connor, K.; Henry, C.; 
359 O'Mahony, D.; Fitzgerald, A.P.; Shanahan, F.; Twomey, C.; Hill, C.; Ross, R.P.; 
360 O'Toole, P.W. Composition, variability, and temporal stability of the intestinal 
361 microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 4586-4591.
362 12. Manichanh, C.; Rigottier-Gois, L.; Bonnaud, E.; Gloux, K.; Pelletier, E.; 
363 Frangeul, L.; Nalin, R.; Jarrin, C.; Chardon, P.; Marteau, P.; Roca, J.; Dore, J. 
364 Reduced diversity of faecal microbiota in Crohn's disease revealed by a 
365 metagenomic approach. Gut 2006, 55, 205-211.
366 13. De Goffau, M.C.; Luopajärvi, K.; Knip, M.; Ilonen, J.; Ruohtula, T.; Härkönen, 
367 T.; Orivuori, L.; Hakala, S.; Welling, G.W.; Harmsen, H.J.; Vaarala, O. Fecal 
368 microbiota composition differs between children with ß-cell autoimmunity and 
369 those without. Diabetes 2013, 62, 1238-1244.
370 14. Navab-Moghadam, F.; Sedighi, M.; Khamseh, M.E.; Alaei-Shahmiri, F.; Talebi, 
371 M.; Razavi, S.; Amirmozafari, N. The association of type II diabetes with gut 
372 microbiota composition. Microb. Pathog. 2017, 110, 630-636.
373 15. Ferrocino, I.; Ponzo, V.; Gambino, R.; Zarovska, A.; Leone, F.; Monzeglio, C.; 
374 Goitre, I.; Rosato, R.; Romano, A.; Grassi, G.; Broglio, F.; Cassader, M.; Cocolin, 
Page 17 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
18
375 L.; Bo, S. Changes in the gut microbiota composition during pregnancy in patients 
376 with gestational diabetes mellitus (GDM). Sci. Rep. 2018, 8, 12216.
377 16. Nylund, L.; Kaukinen, K.; Lindfors, K. The microbiota as a component of the 
378 celiac disease and non-celiac gluten sensitivity. Clin. Nutr. Exp 2016, 6, 17-24.
379 17. López-Contreras, B.E.; Morán-Ramos, S.; Villarruel-Vázquez, R.; Macías-
380 Kauffer, L.; Villamil-Ramírez, H.; León-Mimila, P.; Vega-Badillo, J.; Sánchez-
381 Muñoz, F.; Llanos-Moreno, L.E.; Canizalez-Román, A.; del Río-Navarro, B.; 
382 Ibarra-González, I.; Vela-Amieva, M.; Villarreal-Molina, T.; Ochoa-Leyva, A.; 
383 Aguilar-Salinas, C.A.; Canizales-Quinteros, S. Composition of gut microbiota in 
384 obese and normal-weight Mexican school-age children and its association with 
385 metabolic traits. Pediatr. Obes. 2018, 13, 381-388.
386 18. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: 
387 Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
388 19. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human 
389 health and disease. Oxidative Med. Cell. Longevity 2009, 2, 270-278.
390 20. Ozdal, T.; Sela, D.A.; Xiao, J.; Boyacioglu, D.; Chen, F.; Capanoglu, E. The 
391 reciprocal interactions between polyphenols and gut microbiota and effects on 
392 bioaccessibility. Nutrients 2016, 8, 78.
393 21. Scalbert, A.; Morand, C.; Manach, C.; Rémésy, C. Absorption and metabolism of 
394 polyphenols in the gut and impact on health. Biomed. Pharmacother. 2002, 56, 
395 276-282.
396 22. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.E.; Tognolini, M.; Borges, G.; 
397 Crozier, A. Dietary (poly)phenolics in human health: Structures, bioavailability, 
398 and evidence of protective effects against chronic diseases. Antioxid. Redox 
399 Signal. 2013, 18, 1818-1892.
Page 18 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
19
400 23. Rechner, A.R.; Kuhnle, G.; Bremner, P.; Hubbard, G.P.; Moore, K.P.; Rice-
401 Evans, C.A. The metabolic fate of dietary polyphenols in humans. Free Radic. 
402 Biol. Med. 2002, 33, 220-235.
403 24. Silberberg, M.; Morand, C.; Mathevon, T.; Besson, C.; Manach, C.; Scalbert, A.; 
404 Remesy, C. The bioavailability of polyphenols is highly governed by the capacity 
405 of the intestine and of the liver to secrete conjugated metabolites. Eur. J. Nutr. 
406 2006, 45, 88-96.
407 25. Clifford, M.N. Diet-derived phenols in plasma and tissues and their implications 
408 for health. Planta Med. 2004, 70, 1103-1114.
409 26. Yang, F.; De Villiers, W.J.S.; McClain, C.J.; Varilek, G.W. Green tea polyphenols 
410 block endotoxin-induced tumor necrosis factor- production and lethality in a 
411 murine model. J. Nutr. 1998, 128, 2334-2340.
412 27. Katiyar, S.K.; Matsui, M.S.; Elmets, C.A.; Mukhtar, H. Polyphenolic Antioxidant 
413 (-)-Epigallocatechin-3-Gallate from Green Tea Reduces UVB-Induced 
414 Inflammatory Responses and Infiltration of Leukocytes in Human Skin. 
415 Photochem. Photobiol. 1999, 69, 148-153.
416 28. Babu, P.V.A.; Liu, D. Green tea catechins and cardiovascular health: An update. 
417 Curr. Med. Chem. 2008, 15, 1840-1850.
418 29. Chen, H.; Sang, S. Biotransformation of tea polyphenols by gut microbiota. J. 
419 Funct. Foods 2014, 7, 26-42.
420 30. Chen, B.; Zhou, J.; Meng, Q.; Zhang, Y.; Zhang, S.; Zhang, L. Comparative 
421 analysis of fecal phenolic content between normal and obese rats after oral 
422 administration of tea polyphenols. Food. Funct. 2018, 9, 4858-4864.
Page 19 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
20
423 31. Marín, L.; Miguélez, E.M.; Villar, C.J.; Lombó, F. Bioavailability of dietary 
424 polyphenols and gut microbiota metabolism: Antimicrobial properties. BioMed 
425 Res. Int. 2015, 2015, 905215.
426 32. Fu, Z.; Liska, D.; Talan, D.; Chung, M. Cranberry Reduces the Risk of Urinary 
427 Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review 
428 and Meta-Analysis. J Nutr. 2017, 147, 2282-2288.
429 33. Peron, G.; Pellizzaro, A.; Brun, P.; Schievano, E.; Mammi, S.; Sut, S.; 
430 Castagliuolo, I.; Dall'Acqua, S. Antiadhesive Activity and Metabolomics 
431 Analysis of Rat Urine after Cranberry (Vaccinium macrocarpon Aiton) 
432 Administration. J. Agric. Food Chem. 2017, 65, 5657-5667.
433 34. Peron, G.; Sut, S.; Pellizzaro, A.; Brun, P.; Voinovich, D.; Castagliuolo, I.; 
434 Dall'Acqua, S. The antiadhesive activity of cranberry phytocomplex studied by 
435 metabolomics: Intestinal PAC-A metabolites but not intact PAC-A are identified 
436 as markers in active urines against uropathogenic Escherichia coli. Fitoterapia 
437 2017, 122, 67-75.
438 35. Monagas, M.; Urpi-Sarda, M.; Sánchez-Patán, F.; Llorach, R.; Garrido, I.; 
439 Gómez-Cordovés, C.; Andres-Lacueva, C.; Bartolomé, B. Insights into the 
440 metabolism and microbial biotransformation of dietary flavan-3-ols and the 
441 bioactivity of their metabolites. Food. Funct. 2010, 1, 233-253.
442 36. De Santis, S.; Cavalcanti, E.; Mastronardi, M.; Jirillo, E.; Chieppa, M. Nutritional 
443 keys for intestinal barrier modulation. Front. Immunol. 2015, 6, 612.
444 37. Chen, M.X.; Wang, S.Y.; Kuo, C.H.; Tsai, I.L. Metabolome analysis for 
445 investigating host-gut microbiota interactions. J. Formos. Med. Assoc. 2018, 118, 
446 S10-S22.
Page 20 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
21
447 38. Appeldoorn, M.M.; Vincken, J.; Aura, A.; Hollman, P.C.H.; Gruppen, H. 
448 Procyanidin dimers are metabolized by human microbiota with 2-(3,4-
449 dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-γ- valerolactone as the 
450 major metabolites. J. Agric. Food Chem. 2009, 57, 1084-1092.
451 39. Van'T Slot, G.; Mattern, W.; Rzeppa, S.; Grewe, D.; Humpf, H.-. Complex 
452 flavonoids in cocoa: Synthesis and degradation by intestinal microbiota. J. Agric. 
453 Food Chem. 2010, 58, 8879-8886.
454 40. Sánchez-Patán, F.; Monagas, M.; Moreno-Arribas, M.V.; Bartolomé, B. 
455 Determination of microbial phenolic acids in human faeces by UPLC-ESI-TQ 
456 MS. J. Agric. Food Chem. 2011, 59, 2241-2247.
457 41. Moco, S.; Martin, F.-.J.; Rezzi, S. Metabolomics view on gut microbiome 
458 modulation by polyphenol-rich foods. J. Proteome Res. 2012, 11, 4781-4790.
459 42. Cueva, C.; Sánchez-Patán, F.; Monagas, M.; Walton, G.E.; Gibson, G.R.; Martín-
460 Álvarez, P.J.; Bartolomé, B.; Moreno-Arribas, M.V. In vitro fermentation of grape 
461 seed flavan-3-ol fractions by human faecal microbiota: Changes in microbial 
462 groups and phenolic metabolites. FEMS Microbiol. Ecol. 2013, 83, 792-805.
463 43. Piwowarski, J.P.; Granica, S.; Zwierzynska, M.; Stefanska, J.; Schopohl, P.; 
464 Melzig, M.F.; Kiss, A.K. Role of human gut microbiota metabolism in the anti-
465 inflammatory effect of traditionally used ellagitannin-rich plant materials. J. 
466 Ethnopharmacol. 2014, 155, 801-809.
467 44. Jacobs, D.M.; Gaudier, E.; van Duynhoven, J.; Vaughan, E.E. Non-digestible food 
468 ingredients, colonic microbiota and the impact on gut health and immunity: A role 
469 for metabolomics. Curr. Drug Metab. 2009, 10, 41-54.
470 45. Mcdermott, A.J.; Huffnagle, G.B. The microbiome and regulation of mucosal 
471 immunity. Immunology 2014, 142, 24-31.
Page 21 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
22
472 46. González-Mariscal, L.; Betanzos, A.; Nava, P.; Jaramillo, B.E. Tight junction 
473 proteins. Prog. Biophys. Mol. Biol. 2003, 81, 1-44.
474 47. Furuse, M. Molecular basis of the core structure of tight junctions. Cold Spring 
475 Harb Perspect Biol 2010, 2, a002907.
476 48. Yu, D.; Turner, J.R. Stimulus-induced reorganization of tight junction structure: 
477 The role of membrane traffic. Biochim. Biophys. Acta Biomembr. 2008, 1778, 
478 709-716.
479 49. Steed, E.; Balda, M.S.; Matter, K. Dynamics and functions of tight junctions. 
480 Trends Cell Biol. 2010, 20, 142-149.
481 50. Atisook, K.; Madara, J.L. An oligopeptide permeates intestinal tight junctions at 
482 glucose-elicited dilatations. Implications for oligopeptide absorption. 
483 Gastroenterology 1991, 100, 719-724.
484 51. Bischoff, S.C.; Barbara, G.; Buurman, W.; Ockhuizen, T.; Schulzke, J.; Serino, 
485 M.; Tilg, H.; Watson, A.; Wells, J.M. Intestinal permeability - a new target for 
486 disease prevention and therapy. BMC Gastroenterol. 2014, 14, 189.
487 52. Arrieta, M.C.; Bistritz, L.; Meddings, J.B. Alterations in intestinal permeability. 
488 Gut 2006, 55, 1512-1520.
489 53. Tran, L.; Greenwood-Van Meerveld, B. Age-associated remodeling of the 
490 intestinal epithelial barrier. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2013, 68, 1045-
491 1056.
492 54. Mabbott, N.A. A breakdown in communication? Understanding the effects of 
493 aging on the human small intestine epithelium. Clin. Sci. 2015, 129, 529-531.
494 55. Nagpal, R.; Mainali, R.; Ahmadi, S.; Wang, S.; Singh, R.; Kavanagh, K.; 
495 Kitzman, D.W.; Kushugulova, A.; Marotta, F.; Yadav, H. Gut microbiome and 
Page 22 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
23
496 aging: Physiological and mechanistic insights. Nutr. Heal. Aging 2018, 4, 267-
497 285.
498 56. Di Sabatino, A.; Lenti, M.V.; Cammalleri, L.; Corazza, G.R.; Pilotto, A. Frailty 
499 and the gut. Dig. Liver Dis. 2018, 50, 533-541.
500 57. Canani, R.B.; Costanzo, M.D.; Leone, L.; Pedata, M.; Meli, R.; Calignano, A. 
501 Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. 
502 World J. Gastroenterol. 2011, 17, 1519-1528.
503 58. Plöger, S.; Stumpff, F.; Penner, G.B.; Schulzke, J.; Gäbel, G.; Martens, H.; Shen, 
504 Z.; Günzel, D.; Aschenbach, J.R. Microbial butyrate and its role for barrier 
505 function in the gastrointestinal tract. Ann. New York Acad. Sci. 2012, 1258, 52-
506 59.
507 59. Sun, Y.; O'Riordan, M.X.D. Regulation of bacterial pathogenesis by intestinal 
508 short-chain fatty acids. Adv. Appl. Microbiol. 2013, 85, 92-118.
509 60. Matt, S.M.; Allen, J.M.; Lawson, M.A.; Mailing, L.J.; Woods, J.A.; Johnson, 
510 R.W. Butyrate and dietary soluble fiber improve neuroinflammation associated 
511 with aging in mice. Front. Immunol. 2018, 9, 1832.
512 61. Hu, E.; Chen, D.; Wu, J.; Lu, F.; Chen, L.; Zheng, M.; Li, H.; Huang, Y.; Li, J.; 
513 Jin, X.; Gong, Y.; Lin, Z.; Wang, X.; Xu, L.; Chen, Y. High fiber dietary and 
514 sodium butyrate attenuate experimental autoimmune hepatitis through regulation 
515 of immune regulatory cells and intestinal barrier. Cell. Immunol. 2018, 328, 24-
516 32.
517 62. Fachi, J.L.; Felipe, J.S.; Pral, L.P.; da Silva, B.K.; Corrêa, R.O.; de Andrade, 
518 M.C.P.; da Fonseca, D.M.; Basso, P.J.; Câmara, N.O.S.; de Sales, E.; Souza, É.L.; 
519 Dos Santos Martins, F.; Guima, S.E.S.; Thomas, A.M.; Setubal, J.C.; Magalhães, 
520 Y.T.; Forti, F.L.; Candreva, T.; Rodrigues, H.G.; de Jesus, M.B.; Consonni, S.R.; 
Page 23 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
24
521 Farias, A.D.S.; Varga-Weisz, P.; Vinolo, M.A.R. Butyrate Protects Mice from 
522 Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism. 
523 Cell Rep. 2019, 27, 750-761.
524 63. Lin, H.; Barnett, M.P.G.; Roy, N.C.; Joyce, N.I.; Zhu, S.; Armstrong, K.; Helsby, 
525 N.A.; Ferguson, L.R.; Rowan, D.D. Metabolomic analysis identifies 
526 inflammatory and noninflammatory metabolic effects of genetic modification in 
527 a mouse model of Crohn´s disease. J. Proteome Res. 2010, 9, 1965-1975.
528 64. Venkatesh, M.; Mukherjee, S.; Wang, H.; Li, H.; Sun, K.; Benechet, A.P.; Qiu, 
529 Z.; Maher, L.; Redinbo, M.R.; Phillips, R.S.; Fleet, J.C.; Kortagere, S.; 
530 Mukherjee, P.; Fasano, A.; Le Ven, J.; Nicholson, J.K.; Dumas, M.E.; Khanna, 
531 K.M.; Mani, S. Symbiotic bacterial metabolites regulate gastrointestinal barrier 
532 function via the xenobiotic sensor PXR and toll-like receptor 4. Immunity 2014, 
533 41, 296-310.
534 65. Dodd, D.; Spitzer, M.H.; Van Treuren, W.; Merrill, B.D.; Hryckowian, A.J.; 
535 Higginbottom, S.K.; Le, A.; Cowan, T.M.; Nolan, G.P.; Fischbach, M.A.; 
536 Sonnenburg, J.L. A gut bacterial pathway metabolizes aromatic amino acids into 
537 nine circulating metabolites. Nature 2017, 551, 648-652.
538 66. Jennis, M.; Cavanaugh, C.R.; Leo, G.C.; Mabus, J.R.; Lenhard, J.; Hornby, P.J. 
539 Microbiota-derived tryptophan indoles increase after gastric bypass surgery and 
540 reduce intestinal permeability in vitro and in vivo. Neurogastroenterol. Motil. 
541 2018, 30, e13178.
542 67. Bansal, T.; Alaniz, R.C.; Wood, T.K.; Jayaraman, A. The bacterial signal indole 
543 increases epithelial-cell tight-junction resistance and attenuates indicators of 
544 inflammation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 228-233.
Page 24 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
25
545 68. Krishnan, S.; Ding, Y.; Saedi, N.; Choi, M.; Sridharan, G.V.; Sherr, D.H.; 
546 Yarmush, M.L.; Alaniz, R.C.; Jayaraman, A.; Lee, K. Gut Microbiota-Derived 
547 Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and 
548 Macrophages. Cell Rep. 2018, 4, 1099-1111.
549 69. Wlodarska, M.; Luo, C.; Kolde, R.; d'Hennezel, E.; Annand, J.W.; Heim, C.E.; 
550 Krastel, P.; Schmitt, E.K.; Omar, A.S.; Creasey, E.A.; Garner, A.L.; Mohammadi, 
551 S.; O'Connell, D.J.; Abubucker, S.; Arthur, T.D.; Franzosa, E.A.; Huttenhower, 
552 C.; Murphy, L.O.; Haiser, H.J.; Vlamakis, H.; Porter, J.A.; Xavier, R.J. 
553 Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species 
554 Suppresses Inflammation. Cell Host and Microbe 2017, 22, 25-37.
555 70. Valls-Pedret, C.; Lamuela-Raventós, R.M.; Medina-Remón, A.; Quintana, M.; 
556 Corella, D.; Pintó, X.; Martínez-González, M.A.; Estruch, R.; Ros, E. Polyphenol-
557 rich foods in the mediterranean diet are associated with better cognitive function 
558 in elderly subjects at high cardiovascular risk. J. Alzheimer's Dis. 2012, 29, 773-
559 782.
560 71. Chang, S.; Cassidy, A.; Willett, W.C.; Rimm, E.B.; O'Reilly, E.J.; Okereke, O.I. 
561 Dietary flavonoid intake and risk of incident depression in midlife and older 
562 women. Am. J. Clin. Nutr. 2016, 104, 704-714.
563 72. Amasheh, M.; Schlichter, S.; Amasheh, S.; Mankertz, J.; Zeitz, M.; Fromm, M.; 
564 Schulzke, J.D. Quercetin enhances epithelial barrier function and increases 
565 claudin-4 expression in Caco-2 cells. J. Nutr. 2008, 138, 1067-1073.
566 73. Carrasco-Pozo, C.; Morales, P.; Gotteland, M. Polyphenols protect the epithelial 
567 barrier function of Caco-2 cells exposed to indomethacin through the modulation 
568 of occludin and zonula occludens-1 expression. J. Agric. Food Chem. 2013, 61, 
569 5291-5297.
Page 25 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
26
570 74. Tomas-Barberan, F.A.; Selma, M.V.; Espín, J.C. Polyphenols' Gut Microbiota 
571 Metabolites: Bioactives or Biomarkers? J. Agric. Food Chem. 2018, 66, 3593-
572 3594.
573 75. Queipo-Ortuño, M.I.; Boto-Ordóñez, M.; Murri, M.; Gomez-Zumaquero, J.M.; 
574 Clemente-Postigo, M.; Estruch, R.; Cardona Diaz, F.; Andrés-Lacueva, C.; 
575 Tinahones, F.J. Influence of red wine polyphenols and ethanol on the gut 
576 microbiota ecology and biochemical biomarkers. Am. J. Clin. Nutr. 2012, 95, 
577 1323-1334.
578 76. Filosa, S.; Di Meo, F.; Crispi, S. Polyphenols-gut microbiota interplay and brain 
579 neuromodulation. Neural. Regen. Res. 2018, 13, 2055-2059.
580 77. Yang, G.; Bibi, S.; Du, M.; Suzuki, T.; Zhu, M. Regulation of the intestinal tight 
581 junction by natural polyphenols: A mechanistic perspective. Crit. Rev. Food Sci. 
582 Nutr. 2017, 57, 3830-3839.
583 78. Axling, U.; Olsson, C.; Xu, J.; Fernandez, C.; Larsson, S.; Ström, K.; Ahrné, S.; 
584 Holm, C.; Molin, G.; Berger, K. Green tea powder and Lactobacillus plantarum 
585 affect gut microbiota, lipid metabolism and inflammation in high-fat fed 
586 C57BL/6J mice. Nutr. Metab. 2012, 9, 105.
587 79. Everard, A.; Belzer, C.; Geurts, L.; Ouwerkerk, J.P.; Druart, C.; Bindels, L.B.; 
588 Guiot, Y.; Derrien, M.; Muccioli, G.G.; Delzenne, N.M.; De Vos, W.M.; Cani, 
589 P.D. Cross-talk between Akkermansia muciniphila and intestinal epithelium 
590 controls diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 9066-
591 9071.
592 80. Li, J.; Wu, T.; Li, N.; Wang, X.; Chen, G.; Lyu, X. Bilberry anthocyanin extract 
593 promotes intestinal barrier function and inhibits digestive enzyme activity by 
594 regulating the gut microbiota in aging rats. Food. Funct. 2019, 10, 333-343.
Page 26 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
27
595 81. Nieman, D.C.; Kay, C.D.; Rathore, A.S.; Grace, M.H.; Strauch, R.C.; Stephan, 
596 E.H.; Sakaguchi, C.A.; Lila, M.A. Increased Plasma Levels of Gut-Derived 
597 Phenolics Linked to Walking and Running Following Two Weeks of Flavonoid 
598 Supplementation. Nutrients 2018, 10, 1718.
599 82. Dhingra, D.; Michael, M.; Rajput, H.; Patil, R.T. Dietary fibre in foods: A review. 
600 J. Food Sci. Technol. 2012, 49, 255-266.
601 83. Friedman, M. Analysis, Nutrition, and Health Benefits of Tryptophan. Int. J. 
602 Trytophan Res. 2018, 11, 1178646918802282.
603
604
605
606
607
608
609
Page 27 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
28
FIGURES
Figure 1
3 2 4 3
13 12
25
32
44
53
57
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
0
10
20
30
40
50
60
70
Year
N
um
be
r o
f p
ub
lic
at
io
ns
Page 28 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
29
Figure 2
Page 29 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
30
TABLE
Table 1
Intervention/
Condition
Source, dose and length of 
treatment
Model Biofluid/ 
biomatrix 
analyzed
Metabolomic 
approach *
Gut-derived metabolites 
correlated to effects on 
IP
Main outcomes of the study ** Reference
High-fiber diet Laboratory diet composed 
of 30% barley and 70% 
standard AIN-93 for 28 
days
Mouse, healthy Feces Targeted 
GC-MS
Butyrate, propionate, 
acetate
 Butyrate from fiber ↓ pro-inflammatory 
cytokines (IL-17A, IL-6, Cxcl-1)
 ↑ IL-10 and TGF-β mRNA expression 
 ↓ intestinal tract lesions 
 ↑ Claudin-1, occludin and ZO-1
 ↓ bacterial translocation
Hu et al.,
2018 61
Dietary 
fibers
Inulin-enriched 
diet
Laboratory diet 
supplemented with 5% 
cellulose and 25% inulin
for 7 days
Mouse, healthy 
and colonized 
with 1 × 108 
CFU 
Clostridium 
difficile
Feces Targeted 
GC-MS
Butyrate, propionate, 
acetate
 Butyrate from fiber ↓ pro-inflammatory 
cytokines (IL-6, IL-1b, Cxcl-1)
 ↑ anti-inflammatory cytokine IL-10 
 ↓ intestinal tract lesions
 ↑ Claudin-1 and occludin 
 ↓ bacterial translocation
 ↑ intestinal barrier integrity
Fachi et al., 
2019 62
Tryptophan Gavage with 
Clostridium. 
Sporogenes and 
standard chow 
diet
Standard chow (LabDiet 
5k67) containing 0.23% 
tryptophan for 4 weeks 
Mouse, germ 
free colonized 
with 
Clostridium. 
sporogenes by 
oral gavage (~ 1 
× 107 CFU)
Serum Targeted 
LC-MS
Indole 3-propionic acid 
(IPA)
 IPA produced by C. sporogens,
 Colonization with C. sporogenes ↓ intestinal 
permeability
 IPA signals through PXR to fortify the 
intestinal barrier
Dodd eta al.,
2017 65
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Gavage with 
probiotics 
(mice)/
Irritable Bowel 
Disease (IBD) 
(human)
Oral gavage with 0.6-2 × 
108 CFU 
Peptostreptococcus species 
every other day, for 2 weeks 
(mice)
Mouse, dextran 
sodium sulfate-
induced colitis/
Human, 
ulcerative colitis 
and Crohn’s 
disease
Feces Untargeted 
LC-MS
IPA, indoleacrylic acid 
(IA)
 Peptostreptococcus species ↑ barrier 
function through production of IPA and IA
 IA ↓ pro-inflammatory cytokine production 
 IA ↑ intestinal epithelial barrier function
 Microbes of IBD patients have reduced 
ability to cleave mucins and metabolize 
tryptophan
 ↓ mucin utilization by gut bacteria in IBD
 ↓ colonization of microbes that metabolize 
tryptophan in the intestine of IBD
Wlodarska et al.,
2017 69
High-fat diet 
(mice) 
supplemented 
with IPA/ 
Obese T2D 
subjects before 
and after RYGB 
(human)
Daily oral gavage with 20 
mg/kg IPA for 4 
consecutive days (mice)
Mouse, diet- 
induced obese 
(DIO)/ Human, 
obese with type-
2 diabetes
Plasma Targeted and 
Untargeted 
LC-MS, 
GC-MS
IPA, indoxyl 3-sulfuric 
acid (ISA), indole 3-acetic 
acid (IAA)
 IPA ↓ IP in DIO mice
 ↓ IPA, IAA and ISA in obese subjects
 ↑ IPA, IAA and ISA 3 months after RYGB
 IPA ↓ IP in obese subjects
Jennis et al.,
2018 66
Oral bilberry 
anthocyanin 
(BA) 
consumption in 
aging model
Old and young animals 
treated with 3 different BA 
doses (6 animal groups) for 
10 weeks: 
LBA group: 10 mg/kg/dia;
MBA group: 20 mg/kg/dia;
HBA group: 40 mg/kg/dia
Rat,
young (4 
months) and old 
(12 months), 
healthy
Cecal 
content
Targeted 
GC-FID
Butyrate, propionate, 
acetate
 BA ↑ starch-utilizing and butyrate-producing 
bacteria
 BA ↓ inflammatory factors (TNF-α, IL-6) 
and mucosa damages in the colon
Li et al.,
2019 80
Dietary 
polyphenols
Combination of 
flavonoid 
supplementation 
and moderate 
physical 
exercise (45 
min walking 
and 2.5 h 
running)
Capsule containing 329 mg 
total flavonoids: bilberry 
fruit extract (64 mg 
anthocyanins), green tea 
leaf extract (184 mg total 
flavan-3-ols), 104 mg 
quercetin aglycone.
Human, healthy Plasma Targeted 
LC-MS
Hippuric acid, 
3-hydroxyhippuric acid, 
quercetin-3-O-
glucuronide, delphinidin-
3-O-glucoside, 4-
hydroxycinnamic acid, 5-
(3′,4′-dihydroxyphenyl)-
γ-valerolactone, 3-(3-
hydroxy-4-
 Physical exercise ↑ absorption of gut-derived 
flavonoid metabolites 
 Flavonoid consumption associated to 
physical exercise ↓ IP
 Flavonoids and their gut-transformed 
metabolites ↑ intestinal barrier integrity
Nieman et al.,
2019 81
Page 31 of 34
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
32
1 capsule/dia for “walking” 
group; 2 capsules/dia for 
“running” group. 
Supplementation time: 2 
weeks
methoxyphenyl)propanoic 
acid-3-O-glucuronide, 
methoxybenzoic acid 
derivatives, benzaldehyde 
derivatives
* LC-MS: Liquid Chromatography coupled to Mass Spectrometry; GC-MS: Gas Chromatography coupled to Mass Spectrometry; GC-FID: Gas Chromatography coupled to Flame Ionization Detector.
** ↓ indicates “decrease”; ↑ indicates “increase”.
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FIGURE CAPTIONS
Figure 1. The increase of the scientific literature regarding the use of metabolomics in 
the study of the interactions between diet and gut microbiota during the last 11 years. 
Source: PubMed (https://www.ncbi.nlm.nih.gov/pubmed/).
Figure 2. Schematic representation of the mechanisms of action responsible for the 
effects of microbiota-derived dietary metabolites on intestinal permeability.
TABLE CAPTION
Table 1. Summary of the studies involving the application of metabolomics to the study 
of the effects of diet-gut microbiota interactions on intestinal permeability in vivo.
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